Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI-MS) Analyses (original) (raw)
Lysophospholipids Are Potential Biomarkers of Ovarian Cancer
Yijin Xiao
… Biomarkers & Prevention, 2004
View PDFchevron_right
Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis
Robert Newman
Methods in enzymology, 2007
View PDFchevron_right
Facile Titrimetric Assay of Lysophosphatidic Acid in Human Serum and Plasma for Ovarian Cancer Detection
Ranu Agrawal
Journal of Cancer Prevention
View PDFchevron_right
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
ming wu
View PDFchevron_right
Measurement of Phospholipids May Improve Diagnostic Accuracy in Ovarian Cancer
Ashley Molina
PLoS ONE, 2012
View PDFchevron_right
Relative Ratios Enhance the Diagnostic Power of Phospholipids in Distinguishing Benign and Cancerous Ovarian Masses
Rishabh Choudhary
Cancers
View PDFchevron_right
Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column
Martha Nunn
Journal of Chromatography B, 2008
View PDFchevron_right
Detection of Lysophosphatidic Acid in Serum; Towards a Cost Effective Test for Ovarian Cancer
brian james
2017
View PDFchevron_right
High-Throughput Quantification of Lysophosphatidylcholine by Electrospray Ionization Tandem Mass Spectrometry
Wolfgang drobnik
2002
View PDFchevron_right
Lysophosphatidic acid production and action: Validated targets in cancer?
Colin Ferguson
Journal of Cellular Biochemistry, 2004
View PDFchevron_right
Distributed under Creative Commons CC-BY 4.0 Profiling lysophosphatidic acid levels in plasma from head and neck cancer patients
Universiti Kebangsaan Malaysia Dental Science Research
PeerJ, 2020
View PDFchevron_right
Profiling lysophosphatidic acid levels in plasma from head and neck cancer patients
Mustafa Ali Mohd
PeerJ, 2020
View PDFchevron_right
Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry
Harman Dhillon
Oncotarget, 2016
View PDFchevron_right
Rapid Screening of Phospholipid Biomarker Candidates from Prostate Cancer Urine Samples by Multiple Reaction Monitoring of UPLC-ESI-MS/MS and Statistical Approaches
Sangsoo Lim
Bulletin of the Korean Chemical Society, 2014
View PDFchevron_right
Electrospray Ionization Mass Spectrometry Analysis of Lysophospholipids in Human Ascitic Fluids: Comparison of the Lysophospholipid Contents in Malignant vs Nonmalignant Ascitic Fluids
Monique Washington
Analytical Biochemistry, 2001
View PDFchevron_right
Liquid Chromatography/Mass Spectrometry of Phospholipids using Electrospray Ionization
Maria Careri
Analytical Chemistry, 1994
View PDFchevron_right
Simultaneous determination of lysophospholipids by high-performance liquid chromatography with fluorescence detection
Giovanni Camussi
… of Chromatography B: …, 1997
View PDFchevron_right
Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects
Mohammed Jemal
Rapid Communications in Mass Spectrometry, 2009
View PDFchevron_right
Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis
Jack Singer
British journal of cancer, 2005
View PDFchevron_right
Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer
Takayo Kawakami
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
Identification of oxidized phospholipids by electrospray ionization mass spectrometry and LC-MS using a QQLIT instrument
Ana Reis
Free Radical Biology and Medicine, 2011
View PDFchevron_right
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis
Åslaug Helland
PLoS One, 2009
View PDFchevron_right
The role and clinical applications of bioactive lysolipids in ovarian cancer
Yijin Xiao
Journal of the Society for Gynecologic Investigation, 2001
View PDFchevron_right
Lysophosphatidic Acid Activates Lipogenic Pathways and de Novo Lipid Synthesis in Ovarian Cancer Cells
Suzanne Barbour
Journal of Biological Chemistry, 2012
View PDFchevron_right
Circulating Phospholipids as Biomarkers of Breast Cancer: A Review
Dharmica Mistry, Peter French
Breast Cancer: Basic and Clinical Research, 2016
View PDFchevron_right
Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer
Takuji Fujita
Cancer Letters, 2003
View PDFchevron_right
Application of Probe Electrospray Ionization Mass Spectrometry (PESI-MS) to Clinical Diagnosis: Solvent Effect on Lipid Analysis
Hiroshi Nonami
Journal of the American Society for Mass Spectrometry, 2012
View PDFchevron_right
Profiling of human urinary phospholipids by nanoflow liquid chromatography/tandem mass spectrometry
Hanna Kim
The Analyst, 2008
View PDFchevron_right